Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02677701 · ClinicalTrials.gov registry record · Phase 4
Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF)
A Phase 4 study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 119
- Enrollment target
NCT02677701 is a Phase 4 study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 119 participants.
The verdict
NCT02677701, a Phase 4 study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 119 participants
- Enrollment target
Study Summary
This is a study to examine the effect of combining chronic oral azithromycin with inhaled tobramycin in adolescent and adult subjects with cystic fibrosis who are chronically infected with P. aeruginosa.
Interventions
- DRUG azithromycin
- DRUG placebo (for azithromycin)
- DRUG inhaled tobramycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2016-10-21 |
| Est. Completion | 2020-02-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02677701
The ClinicalTrials.gov registry entry for NCT02677701 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which azithromycin is the first listed.
NCT02677701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02677701 about?
NCT02677701 is a clinical study titled "Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF)". This is a study to examine the effect of combining chronic oral azithromycin with inhaled tobramycin in adolescent and adult subjects with cystic fibrosis who are chronically infected with P. aeruginosa.
What is the current status of trial NCT02677701?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 119 participants. The study started on 2016-10-21. Estimated completion is 2020-02-13.
What interventions are being tested in trial NCT02677701?
The interventions under investigation include: azithromycin (DRUG), placebo (for azithromycin) (DRUG), inhaled tobramycin (DRUG).
Who is sponsoring clinical trial NCT02677701?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.